精准医学时代遗传性疾病的分子诊断

doi:10.16150/j.1671-2870.2018.02.003

摘要/Abstract

中图分类号:

R715.5

李牛, 王剑. 精准医学时代遗传性疾病的分子诊断[J]. 诊断学理论与实践, 2018, 17(02): 136-140.

[1] Boycott KM, Rath A, Chong JX, et al. International coo-peration to enable the diagnosis of all rare genetic di-seases[J]. Am J Hum Genet,2017,100(5):695-705.
[2] 钱欣, 罗玉琴, 徐晓姹, 等. 2619例高龄孕妇羊水细胞染色体核型分析[J]. 中华医学遗传学杂志,2009,26(6):712-713.
[3] 张鼎, 胡小梅, 胡爱武. 荧光原位杂交技术及其在遗传学中的应用进展[J]. 中华全科医学,2010,8(6):762-764.
[4] Shen Y, Wu BL. Microarray-based genomic DNA profi-ling technologies in clinical molecular diagnostics[J]. Clin Chem,2009,55(4):659-669.
[5] Hu L, Yao X, Huang H, et al. Clinical significance of germline copy number variation in susceptibility of human diseases[J]. J Genet Genomics,2018,45(1):3-12.
[6] Schouten JP, McElgunn CJ, Waaijer R, et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification[J]. Nucleic Acids Res,2002,30(12):e57.
[7] Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors[J]. Proc Natl Acad Sci U S A,1977,74(12):5463-5467.
[8] Hehir-Kwa JY, Claustres M, Hastings RJ, et al. Towards a European consensus for reporting incidental findings during clinical NGS testing[J]. Eur J Hum Genet,2015, 23(12):1601-1606.
[9] Meienberg J, Bruggmann R, Oexle K, et al. Clinical sequencing: is WGS the better WES?[J]. Hum Genet,2016,135(3):359-362.
[10] Retterer K, Juusola J, Cho MT, et al. Clinical application of whole-exome sequencing across clinical indications[J]. Genet Med,2016,18(7):696-704.
[11] Caspar SM, Dubacher N, Kopps AM, et al. Clinical sequencing: From raw data to diagnosis with lifetime value[J]. Clin Genet,2018,93(3):508-519.
[12] Byron SA, van Keuren-Jensen KR, Engelthaler DM, et al. Translating RNA sequencing into clinical diagnostics: opportunities and challenges[J]. Nat Rev Genet,2016,17(5):257-271.
[13] Kremer LS, Wortmann SB, Prokisch H. "Transcriptomics": molecular diagnosis of inborn errors of metabolism via RNA-sequencing[J/OL]. Inherit Metab Dis,2018-01-25[2018-03-19]. https://www.ncbi.nlm.nih.gov/pubmed/29372369.
[14] Kimble DC, Lach FP, Gregg SQ, et al. A comprehensive approach to identification of pathogenic FANCA variants in Fanconi anemia patients and their families[J]. Hum Mutat,2018,39(2):237-254.
[15] Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies[J]. Am J Hum Genet,2010,86(5):749-764.
[16] Hu X, Li N, Xu Y, et al. Proband-only medical exome sequencing as a cost-effective first-tier genetic diagnostic test for patients without prior molecular tests and clinical diagnosis in a developing country: the China experience[J/OL]. Genet Med,2017-11-02[2018-03-19].https://www.ncbi.nlm.nih.gov/pubmed/29095814.
[17] Alfares A, Aloraini T, Subaie LA, et al. Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing[J/OL]. Genet Med,2018-03-22[2018-04-09].https://www.ncbi.nlm.nih.gov/pubmed/29565419.
[18] Posey JE, Harel T, Liu P, et al. Resolution of disease phenotypes resulting from multilocus genomic variation[J]. N Engl J Med,2017,376(1):21-31.
[19] Kalia SS, Adelman K, Bale SJ, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics[J]. Genet Med,2017,19(2):249-255.
[20] Kearney HM, Thorland EC, Brown KK, et al. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants[J]. Genet Med,2011,13(7):680-685.
[21] Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med,2015,17(5):405-424.
[22] National Society of Genetic Counselors' Definition Task Force, Resta R, Biesecker BB, et al. A new definition of Genetic Counseling: National Society of Genetic Counselors' Task Force report[J]. J Genet Couns,2006,15(2):77-83.
[23] Tarailo-Graovac M, Shyr C, Ross CJ, et al. Exome sequencing and the management of neurometabolic disorders[J]. N Engl J Med,2016,374(23):2246-2255.

精准医学时代遗传性疾病的分子诊断

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	沈银忠. 《人类免疫缺陷病毒感染/艾滋病合并结核分枝杆菌感染诊治专家共识》解读[J]. 诊断学理论与实践, 2022, 21(04): 431-436.
[2]	李惠, 冯洁, 韩立中. 高通量测序技术分析无特定病原体级实验小鼠肠道的菌群组成[J]. 诊断学理论与实践, 2020, 19(1): 55-62.
[3]	余舒文, 方正滢, 谢静远. 基因检测在慢性肾脏病诊治中的应用及进展[J]. 诊断学理论与实践, 2020, 19(06): 613-617.
[4]	叶蕾, 李浩榕. 良恶性甲状腺结节的分子鉴别诊断进展[J]. 诊断学理论与实践, 2020, 19(04): 334-338.
[5]	杜云志, 冯菁华, 常春康. 二代测序技术在骨髓增生异常综合征临床诊断和治疗决策中的应用进展[J]. 诊断学理论与实践, 2019, 18(06): 685-671.
[6]	汪婷婷, 郑乃盛, 袁向亮, 沈立松. 基于16S rRNA高通量测序技术分析小鼠实验性结肠炎肠道菌群结构特征[J]. 诊断学理论与实践, 2019, 18(03): 263-270.
[7]	陆静, 胥雨菲, 卿艳荣, 韩聪, 李牛, 郁婷婷, 姚如恩, 王剑. 一个Rett综合征合并努南综合征家系的基因诊断[J]. 诊断学理论与实践, 2018, 17(02): 147-150.
[8]	刘文恩, 蓝优. 新一代测序技术在临床微生物检测中的应用[J]. 诊断学理论与实践, 2018, 17(02): 127-131.
[9]	张月萍. 染色体核型分析的技术进展及应用原则[J]. 诊断学理论与实践, 2017, 16(03): 241-244.
[10]	陈军, 卢洪洲,. 结核分枝杆菌核酸检测的临床应用[J]. 诊断学理论与实践, 2015, 14(01): 10-12.
[11]	朱雄增,. 恶性淋巴瘤的分子诊断[J]. 诊断学理论与实践, 2014, 13(01): 34-38.
[12]	应建明, 邱田,. 肺癌表皮生长因子基因突变和间变性淋巴瘤激酶融合基因的规范化检测[J]. 诊断学理论与实践, 2013, 12(06): 591-595.
[13]	郑昭璟, 傅启华,. 下一代测序技术在单基因遗传性疾病分子诊断中的应用[J]. 诊断学理论与实践, 2013, 12(04): 390-395.
[14]	吕建新, 张杰,. 线粒体遗传性疾病的基因诊断[J]. 诊断学理论与实践, 2013, 12(04): 381-386.
[15]	郭文婷, 孙莲花, 徐汪洋, 马建芳, 陈生弟, 冀保军, 孙福廷, 袁文涛, 黄薇, 王铸钢, 顾鸣敏,. 腓骨肌萎缩症2型大家系的基因定位及分子诊断[J]. 诊断学理论与实践, 2013, 12(01): 32-37.